Press Releases
Further European Regulatory Review Clarifies and Confirms Prior CHMP Position on Positive Benefit-Risk Balance for Pioglitazone-Containing Products
Takeda Pharmaceutical Company Limited announced that at the request of the European Commission (EC), the European Medicines Agency (EMA)’s Committee for Medical Products for Human Use (CHMP) has clarified the label changes for pioglitazone-containing medicines recommended in July of...
Press Releases
Cook Medical’s Zilver® PTX® Drug-Eluting Stent Technology Receives Unanimous Recommendation from FDA Advisory Committee
The Zilver® PTX® Drug-Eluting Stent, the first device of its kind developed to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA), has received a unanimous recommendation from the Food and Drug Administration’s (FDA) Circulatory System...
Press Releases
Hybrigenics and Servier enter into a licence and research collaboration agreement in oncology and other therapeutic fields
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, and Servier, the largest French privately-owned pharmaceutical company, announces today that they have signed a licence and research collaboration agreement in the field of deubiquitinating enzymes (DUBs) applied...
Press Releases
Global Bio-Pharma Clinical Leaders Call for Industry Transformation at 21st Annual Partnerships in Clinical Trials
Clinical development, outsourcing and operations decision makers from the world’s top bio-pharmaceutical and medical device manufacturers and their clinical research partners will meet on March 4-7, 2012 at the 21st Annual Partnerships in Clinical Trials (PCT) conference in Orlando,...
Press Releases
Genetic Technologies Limited Appoints Dr. Mervyn Cass as Company Director
The Board of Directors of Genetic Technologies Limited has with great pleasure appointed Dr. Mervyn Cass as a non-executive Director of the Company. Dr. Cass is a practicing medical practitioner and, after 28 years as the senior partner in...
Press Releases
IBA’s Family of Proton Beam Solutions Suits Diverse Budgets, Sites and Clinical Needs
IBA Particle Therapy now offers a range of Proton Therapy solutions for cancer specialty centers planning to treat from 250 to 2,000 patients annually with protons. The Proteus® series of Proton Therapy solutions can accommodate disparate budgets, building sites,...
Press Releases
TerraMedica To Become Fortel Analytics Fortel Analytics
Effective today, TerraMedica has changed its name to Fortel Analytics to reflect their focus on managing healthcare fraud and abuse prevention through advancing new and innovative predictive solutions, analysis methods and analytical technology. “Today we are...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.